RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

VICTORY CAPITAL MANAGEMENT INC's Holding History (CIK: 0001040188)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 49,658 Value ($000) $203 Avg Close $4.95 Range $3.81 - $7.18
Q3 2025
Shares 38,345 Value ($000) $187 Avg Close $5.25 Range $4.45 - $7.15
Q2 2025
Shares 37,058 Value ($000) $188 Avg Close $4.91 Range $3.79 - $6.11
Q1 2025
Shares 36,363 Value ($000) $192 Avg Close $7.29 Range $5.19 - $12.36
Q4 2024
Shares 39,913 Value ($000) $270 Avg Close $6.72 Range $5.60 - $9.55
Q3 2024
Shares 27,394 Value ($000) $181 Avg Close $7.17 Range $5.88 - $8.73
Q2 2024
Shares 21,891 Value ($000) $164 Avg Close $8.72 Range $6.75 - $10.66
Q1 2024
Shares 19,293 Value ($000) $192 Avg Close $11.14 Range $8.68 - $15.74
Q4 2023
Shares 20,441 Value ($000) $202 Avg Close $7.13 Range $4.97 - $11.17
Q3 2023
Shares 15,246 Value ($000) $117 Avg Close $9.98 Range $6.44 - $16.75
Q2 2023
Shares 12,334 Value ($000) $92 Avg Close $7.00 Range $4.54 - $10.45
Q1 2023
Shares 12,622 Value ($000) $84 Avg Close $7.93 Range $6.40 - $9.73
Q4 2022
Shares 13,197 Value ($000) $102 Avg Close $9.81 Range $7.04 - $13.29
Q3 2022
Shares 12,062 Value ($000) $128 Avg Close $10.13 Range $7.48 - $14.18
Q2 2021
Shares 6,620 Value ($000) $242 Avg Close $29.60 Range $19.68 - $38.39